CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Accumulated Other Comprehensive Income (Loss)	Retained Earnings
Beginning Balance at Dec. 31, 2022	$ 955,169	$ 197,003	$ (695)	$ 758,861
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	142,897			142,897
Dividends declared	(42,327)			(42,327)
Other comprehensive income (loss), net of tax	(304)		(304)
Share repurchases under buyback program	(18,808)	(2,455)		(16,353)
Issuance of shares upon exercise of common stock options	1,413	1,413
Repurchase of shares for tax payments related to the vesting and exercise of share-based grants	(12,132)	(12,132)
Stock-based compensation expense	19,429	19,429
Ending Balance at Dec. 31, 2023	1,045,337	203,258	(999)	843,078
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	138,401			138,401
Dividends declared	(50,246)			(50,246)
Other comprehensive income (loss), net of tax	73		73
Share repurchases under buyback program	(4,661)	(367)		(4,294)
Issuance of shares upon exercise of common stock options	21	21
Repurchase of shares for tax payments related to the vesting and exercise of share-based grants	(17,334)	(17,334)
Stock-based compensation expense	16,775	16,775
Ending Balance at Dec. 31, 2024	1,128,366	202,353	(926)	926,939
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	135,056			135,056
Dividends declared	(55,340)			(55,340)
Other comprehensive income (loss), net of tax	50		50
Share repurchases under buyback program	(31,969)	(2,277)		(29,692)
Issuance of shares upon exercise of common stock options	0
Repurchase of shares for tax payments related to the vesting and exercise of share-based grants	(10,932)	(10,932)
Stock-based compensation expense	19,066	19,066
Ending Balance at Dec. 31, 2025	$ 1,184,297	$ 208,210	$ (876)	$ 976,963